Aerie Pharmaceuticals, Inc. Debt Instrument, Convertible, Conversion Ratio
Aerie Pharmaceuticals, Inc. had Debt Instrument, Convertible, Conversion Ratio of 4.00% as of 2019-09-04, per its 10-Q filed 2022-11-04.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionRatio1 · last filed 2022-11-04
- 2019-09-04: Debt Instrument, Convertible, Conversion Ratio 4.00%.
| Period end | Debt Instrument, Convertible, Conversion Ratio |
|---|---|
| 2019-09-04 | 4.00% 10-Q · filed 2022-11-04 |